Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | — | — |
Kinrix instead of DTaP administration in a 15 months-old patient; Kinrix instead of DTaP administration in a 15 months-old patient; received Kinrix instead of DTaP (as a 4th dose in the schedule); This non-serious case was reported by a physician via call center representative and described the occurrence of wrong vaccine administered in a 15-month-old female patient who received DTPa-IPV (Kinrix) for prophylaxis. Co-suspect products included DTPa (DTPa vaccine) for prophylaxis. On 09-OCT-2025, the patient received the 4th dose of Kinrix. The patient did not receive DTPa vaccine. On 09-OCT-2025, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix instead of DTaP administration in a 15 months-old patient), inappropriate age at vaccine administration (Verbatim: Kinrix instead of DTaP administration in a 15 months-old patient) and inappropriate schedule of vaccine administered (Verbatim: received Kinrix instead of DTaP (as a 4th dose in the schedule)). The outcome of the wrong vaccine administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-OCT-2025 A physician asked how to proceed. The vaccine administration facility was the same as primary reporter. Patients, initials, date of birth, vaccine lot and expiration date were unknown by the reporter. The batch number was not provided upon follow- up with the reporter.